VKValentina G. Kudrina

Valentina G. Kudrina

*This is an algorithmically generated author record based on publicly available information.

Valentina G. Kudrina has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Оptimization of the reason for the call «Heart condition (pain behind the sternum)» for NSR teams: characteristics of measures and evaluation of the results of implementation

    by Alexey A. Shumkin, Valentina G. Kudrina, Natalia M. Zhilina, А. А. Шумкин, В. Г. Кудрина, Н. М. Жилина

    The purpose of the study was to analyze the database and report forms of call cards with the reason «Heart trouble (chest pain)» and with the diagnosis code «I21» according to ICD-10 in the Emergency Management System program for the period 2019–23, to develop and implement optimization measures and evaluate the results implementations for the period 16.03.24–15.03.25 The materials of the database and reporting forms of call maps of the NSR station for two periods were used: 2019–23 (before the implementation of optimization measures) and 16.03.24–15.03.25 (after implementation), analytical and statistical methods were applied. The results of the study. When providing emergency medical care to patients with acute myocardial infarction, the proportion of clinical deaths in general medical teams decreased by 4 times (from 0.8% to 0.2%) and by 3 times (from 3.8% to 1.2%) in anesthesiology and intensive care teams relative to the initial study period. In 2024, relative to 2023. The number of patients in severe and moderate severity diagnosed with acute myocardial infarction transferred to the anesthesiology and intensive care teams decreased by 2 times due to a twofold increase in the proportion of calls made by anesthesiology and intensive care teams to patients with acute myocardial infarction (from 14.9% to 28.7%) after the introduction of an optimized reason the challenge. Conclusion. The creation and introduction of the reason for the call «A man over 40 years old with a bad heart (pain behind the sternum)», which is specialized for anesthesiology and intensive care teams, made it possible to increase the availability and improve the quality of NSR care for patients with acute coronary syndrome with ST segment elevation, with other diagnoses of category «I» according to ICD-10, requiring participation of anesthesiology and intensive care teams (from 26.8% to 38.7%). This reason for the call is recommended for implementation in the work of NSR stations, which include teams of anesthesiology and intensive care.

  • Vitamin K deficiency in critically ill patients

    by A.I. Baranich, A.A. Sychev, I.A. Savin, O.A. Gadzhieva, V.G. Kudrina

    Maintaining hemostasis balance in critically ill patients is one of the most complex clinical challenges. Among many factors influencing coagulation, vitamin K is an essential cofactor in synthesis of key proteins of blood clotting system. Vitamin K deficiency in ICU patients is still a largely underestimated problem, and clinical approaches are limited to vitamin K correction only in patients with hemorrhagic complications via intake of vitamin K antagonists. This review is devoted to vitamin K deficiency in critically ill patients, including risk factors, prevention and treatment.

  • Causes and microbiological spectrum of brain abscesses: modern data

    by A.I. Baranich, A.A. Sychev, I.A. Savin, N.V. Kurdyumova, M.V. Sukhorukova, Z.SH. Veliev, D.S. Korotkov, K.O. Kakurin, V.G. Kudrina

    Brain abscesses are relatively rare, yet they are life-threatening infections with high risk of persistent neurological impairment in survivors. Effectiveness of therapy depends on understanding the range of probable pathogens. This enables optimal empirical therapy avoiding broad-spectrum combinations and associated risks of drug-drug interactions. Available Russian literature predominantly contains case reports and reviews resulting in a lack of up-to-date epidemiological data on brain abscesses. Objective. To analyze current etiological and epidemiological data in a cohort of patients with verified brain abscesses. Material and methods. A single-center retrospective study enrolled 41 patients with primary brain abscesses between 2022 and 2025. The diagnosis was confirmed by contrast-enhanced MRI and/or intraoperative findings. Exclusion criteria: extracranial abscess, concomitant intracranial or head soft tissue infection and recurrent abscesses. Results. Abscesses occurred as complications of neurosurgery in 16 (39%) out of 41 patients, ENT diseases — in 4 (9.8%) cases. Odontogenic route of infection was established in 4 (9.8%) cases, and 2 (4.9%) patients had previous traumatic brain injury. Etiology was unknown in 36.6% of cases. Gram-positive cocci prevailed: Staphylococcus spp. (26.8%) and Streptococcus spp. (19.5%). Conclusion. These data highlight the need for regular updating of local epidemiological data on brain abscesses. A thorough analysis of anamnestic data in these patients can enable informed and timely prescription of appropriate empirical antimicrobial therapy. Choice of this therapy depends crucially on spectrum of probable pathogens, especially in the absence of microbiological verification.

  • The Actual Duration of Chemotherapy in Patients with Drug-Resistant Tuberculosis as a Basis for Calculating the Need for Anti-tuberculosis Drugs

    by K. A. Glebov, S. A. Sterlikov, V. G. Kudrina, D. A. Kashirin

    The objective: to study the actual duration of chemotherapy in patients registered for treatment with drug-resistant tuberculosis regimens and the factors providing impact on it. Subjects and Methods. Using the Kaplan-Meier and Cox regression methods, the duration of treatment of 23,798 cases of tuberculosis in Russia was analyzed. Results. All studied factors, including the registration group, chemotherapy regimen, HIV status, and gender, independently influenced the duration of period from treatment registration to successful treatment. However, the registration group and chemotherapy regimen had the greatest impact. Only the chemotherapy regimen had a statistically significant effect on the duration of treatment until failure. All factors except the gender had an independent effect on the duration of treatment until death. However, the greatest impact on tuberculosis-related deaths was exerted by the patient group and treatment regimen, while the most significant impact on other causes was exerted by the registration group and HIV status. Independent influence on the duration of treatment before loss to follow-up included the initiation of treatment after chemotherapy failure and initiation of an empirical treatment regimen. The duration of treatment until transferred out outcome was not affected by any of these factors. Conclusion. The obtained results will enable the development of a model for calculating the need for anti-tuberculosis drugs, taking into account the actual duration of treatment.

  • Systemic thrombolysis in postoperative neurosurgical patients with massive pulmonary embolism (case series and review)

    by A.I. Baranich, A.A. Sychev, S.B. Yakovlev, I.A. Savin, Z.SH. Veliev, T.A. Abramov, N.V. Kurdyumova, D.S. Korotkov, V.G. Kudrina

    Neurosurgical patients represent a high-risk group for pulmonary embolism (PE). Patients with PE and high risk of death require immediate reperfusion therapy—mechanical reperfusion or systemic thrombolysis. Thrombolytic therapy (TLT) provides rapid reduction of obstruction and decreases pulmonary artery pressure, but it is associated with high risk of hemorrhagic complications. An absolute contraindication for TLT is central nervous system disease. When choosing a treatment strategy, one should consider PE-related risk of death with likelihood and consequences of intracranial hemorrhage. This article describes TLT in neurosurgical patients with massive PE and high risk of death over a 4.5-year follow-up period.

  • Open Access

    Analysis of Predictors of Unfavorable Outcomes of Tuberculosis Treatment in Indigenous Population of the North

    by D. V. Kochetkov, Yu. V. Mikhaylova, V. G. Kudrina, Ю. В. Михайлова

    The objective : to study factors influencing treatment outcomes in new tuberculosis patients from indigenous populations of the North (IPN) living in the Yamalo-Nenets Autonomous Area (YNAA). Subjects and Methods . A retrospective cohort study of treatment outcomes of new patients registered for treatment with drug-susceptible tuberculosis regimens in the Yamalo-Nenets Autonomous Area in 2010-2022 was conducted. A factor analysis of predictors of unfavorable chemotherapy outcomes in patients from indigenous population was performed. Results . Among patients from indigenous population, there is a lower proportion of successful treatment (58.79%) than among non-native permanent residents (68.45%; p = 0.001) due to high level of consequent drug resistance detection and a higher proportion of patients transferred for treatment with relevant chemotherapy regimens (p < 0.0001), as well as a higher proportion of chemotherapy failures (p = 0.001), in some patients it was associated with alcohol dependence syndrome (aOR = 2.80; p = 0.045), and late detection of tuberculosis (p = 0.01). To reduce the proportion of treatment failures among indigenous populations, it is advisable to consider their annual fluorographic examination.

  • Correction of the effect of direct oral and parenteral anticoagulants in hemorrhagic stroke

    by A.I. Baranich, A.A. Sychev, I.A. Savin, V.G. Kudrina, A.V. Kozlov

    Background. Hemorrhagic stroke is associated with high risk of adverse outcome and follows intake of anticoagulants and antiplatelet agents in 25% of cases. The latest clinical guidelines of the Neurocritical Care Society for correction (reversal) of the effect of anticoagulants and antiplatelet agents in hemorrhagic stroke were published in 2016. Material and methods. In accordance with PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases to a depth of 5 years and selected 48 articles. Results and discussion. Direct oral anticoagulants are currently common. To reverse their effect, one can use specific antidotes (idarucizumab is recommended for dabigatran, andexanet alfa (not yet registered In Russia) for factor Xa inhibitors (rivaroxaban, apixaban)) and combination of prothrombin complex concentrate and tranexamic acid. Protamine sulfate is antidote for unfractionated and low molecular weight heparins. Protamine sulfate completely inactivates unfractionated heparin, but it is less effective against low molecular weight heparin. It is characterized by high probability of anaphylactic reactions, especially after repeated administrations. The effectiveness of andexanet alpha and activated factor VII for reversing the effect of low molecular weight heparin is being studied. Fondaparinux sodium is used for heparin-induced thrombocytopenia. Protamine sulfate is ineffective for reversing the effect of fondaparinux. One can use prothrombin complex concentrate and andexanet alpha, but their effectiveness is unclear. Ciraparantag is being studied in clinical trials. Apparently, ciraparantag is highly effective as an antidote for various anticoagulants. Conclusion. Early hemostatic therapy and reversal of anticoagulant effects in patients with hemorrhagic stroke significantly reduce the risk of adverse outcomes. This problem is being studied. Regular literature review with creation of updated clinical guidelines is needed.


  • Correction of the effect of vitamin K antagonists and antiplatelet agents in hemorrhagic stroke

    by A.I. Baranich, A.A. Sychev, I.A. Savin, V.G. Kudrina, A.V. Kozlov

    Background. Hemorrhagic stroke (HS) is associated with high risk of mortality or disability. To date, up to 25% of HSs are associated with anticoagulants and antiplatelet agents. Early hemostatic therapy and correction of effect of antithrombotic drugs in patients with HS significantly reduce the risk of adverse outcomes. The latest international guidelines on this issue were presented almost 10 years ago. Material and methods. In accordance with the PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases and identified 137 articles. Of these, 52 were enrolled as the most relevant. Results and discussion. Regarding correction of the effect of indirect anticoagulants, various researchers discuss the possibility of either individual dosing or injection of a fixed dose of 4- or 3-factor prothrombin complex (1000—2000 IU regardless of body weight and international normalized ratio). To correct the effect of antiplatelet agents, platelet transfusion and desmopressin are proposed. There is currently no evidence of safety and effectiveness of both methods in patients with HS. Conclusion. The optimal drug for correction of the effect of indirect anticoagulants is 4- or 3-factor prothrombin complex. In the last case, it is necessary to administer factor VIIa or fresh frozen plasma, as well as parenteral form of phytomenadione (vitamin K1) in all cases. The issue of correction of the effects of antiplatelet agents remains open. Regular analysis of available data with updating the guidelines for correction of the effect of anticoagulants and antiplatelet agents in HS is necessary.


  • Drug-drug interactions in clinical practice: a literature review and SWOT analysis

    by V.O. Bogdanova, O.S. Golikova, V.G. Kudrina, Yu.A. Dolgusheva

    The prevalence of significant drug-drug interactions in clinical practice reaches 27%. Multiple comorbidities and advanced age of patients, prescription of multiple medications and inconsistency in drug prescriptions at various stages of medical care can contribute to these interactions. The negative consequences of drug-drug interactions include adverse reactions, decreased effectiveness of pharmacotherapy, increased incidence and duration of hospitalizations, mortality and higher cost of medical care. Difficult prevention of adverse reactions may be due to insufficient awareness of physicians about tools for identifying drug-drug interactions, no standardized approach to polypharmacy and implementation of restrictive lists of medications in geriatric practice. Searching for data was performed in the Pubmed, Embase, Web of Science databases. Data were analyzed in accordance with methodology of SWOT (strengths-weaknesses-opportunities-threats) analysis: identifying factors of internal and external environment, organization and their division into four categories. Positive aspects of drug-drug interactions include drug synergism that may be considered in case of ineffective monotherapy and prescription of multicomponent pharmacotherapy or fixed combinations of drugs. Awareness about potentially dangerous and contraindicated drug combinations, pharmacogenetic testing, deprescribing, reconciliation of drug prescriptions at all stages of medical care and specialized electronic databases of drug-drug interactions can be used in clinical practice and development of decision-making support systems to improve the effectiveness and safety of pharmacotherapy.


  • Assessment of medical organizations managers in personnel management literacy

    by E.A. Berseneva, S.V. Umnov, Yu.A. Chudina, Z.KH. Agamov, V.G. Kudrina

    Effective personnel management is a key professional attribute of managers in the healthcare system. Despite the specifics of management in medical organizations, basic management knowledge remains relevant for all managers, regardless of the economic sector. However, the basic competence of medical organizations’ managers is given undeservedly little attention. We developed a basic competence assessment tool and used it to test the managers of medical organizations. Objective. To assess managers for competence in personnel management and conduct a comparative analysis of the performance of managers depending on various characteristics (gender, age, work experience, etc.). Material and methods. The test «Competence of managers in personnel management» (CMPM-test) has been developed, which identifies areas of development of the manager and highlights topics for further training on personnel management. The test includes 79 questions divided into 6 groups. One hundred eighty-six volunteers were surveyed online using the test. Results. The results indicate different competence levels of managers, although in general it scored low in all respondents. Female respondents performed better than male ones. Similarly, respondents with secondary education performed better than those with university degrees. Respondents who received additional training were more competent. Depending on the work experience, the following patterns were observed: a higher competence among managers with 11-15 years of experience (the highest results) compared to young professionals (total work experience up to 10 years), a lower percentage of correct answers and the lowest level of competence among managers with a total work experience of 31-35 years and more than 36 years. Conclusions. Differences in the competence level of managers in personnel management were revealed depending on gender, education, additional training, and work experience. To explain these differences, more research is needed accounting for other factors that might have affected the results obtained.